Clinical Trials
3 trialsNCT06305754 2026-05-29
MK-2870-009
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT06824467 2026-05-29
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT04270409 2025-12-12
Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
Sanofi
Phase 3 Active not recruiting